Introduction
Approximately half of all new sexually transmitted infections (STIs) occur in people 15 to 24 years old. 1 In a recent national survey, only 27.0% of sexually experienced adolescent females reported STI testing within the past 12 months. 2 Increasing testing among adolescents is vital to identify, treat, and prevent spread of disease. Multiple methods exist to test for chlamydia and gonorrhea in adolescent females, including vaginal swabs (self or provider collected), urine samples, and cervical swabs. While all are acceptable, the Centers for Disease Control and Prevention (CDC) states vaginal swabs are the optimal standard and urine samples may have slightly reduced performance. 3, 4 Cervical examinations are no longer routinely recommended for adolescents. 5 Studies have demonstrated adolescent females prefer less invasive methods (urine and self-collected vaginal swabs) compared to invasive cervical swabs that require a speculum exam. 6, 7 When medically appropriate, honoring patient preferences should be considered. In fact, aligning practice with patient preference may improve adolescent willingness for testing. To accomplish this, clinicians must take into account patient preferences and be willing to use the patient-preferred methods in clinical practice. Our prior work has demonstrated that clinicians rarely select less invasive methods of specimen collection in clinic vignettes. 8 No prior studies have evaluated clinicians' perceptions of adolescents' preference for specimen collection and compared that to the method those clinicians typically select. The aim of this study was 3-fold: (1) determine clinicians' perception of adolescents' preference for specimen collection for gonorrhea/chlamydia testing, (2) compare these perceptions to the collection method those clinicians would select, and (3) describe provider-identified barriers to using the adolescent preferred specimen collection for gonorrhea/chlamydia testing.
Materials and Methods
This was a secondary analysis of an Internet-based cross-sectional survey administered to physicians and advanced practice providers specializing in general pediatrics, pediatric emergency medicine, adolescent medicine, child advocacy, emergency medicine, and obstetrics/gynecology. The survey was a 24-question multiple choice questionnaire. It included questions regarding patient management through hypothetical clinical vignettes of an adolescent female (asymptomatic and symptomatic) requesting chlamydia/gonorrhea testing. Additional questions focused on clinician perceptions of adolescent preferences and barriers to STI testing. The institutional review board of Children's Hospital of Wisconsin approved this study.
Surveys were distributed in 2 phases, each over 9 weeks with 2 reminder emails per phase. Phase 1 was distributed nationally to members of the American Academy of Pediatrics Section of Emergency Medicine, and phase 2 was distributed to advanced practice providers and physicians practicing in general pediatrics, pediatric emergency medicine, adolescent medicine, child advocacy, emergency medicine, and obstetrics/gynecology at 2 urban health care centers. In total, 1397 questionnaires were distributed. Participants were excluded if they were currently in residency training, non-English speaking, or resided outside of the United States. Additionally, incomplete responses (those with 3 or fewer answered questions) were excluded from analysis. 
Results
Three hundred sixty-four clinicians responded to the survey (response rate 26.1%). A total of 328 responses were included in the analysis (33 incomplete and 3 from outside the United States were excluded). Two hundred eightynine (88.4%) clinicians perceived adolescents to prefer urine samples for specimen collection; 37 (11.3%) perceived adolescents to prefer vaginal swabs and 1 (0.3%) clinician perceived adolescents to prefer cervical swabs.
The clinician-perceived preferences were significantly different from the collection method the clinician chose to use for the hypothetical clinical vignettes. Although 326 (99.7%) clinicians perceived adolescents to prefer less invasive methods (urine and vaginal), only 260 (81.0%) selected this method in the asymptomatic female vignette, P < .05, and only 119 (37.0%) selected this method in the symptomatic female vignette, P < .05. Conversely, although only 1 (0.3%) clinician perceived adolescents prefer cervical swabs, 60 (18.7%), P < .05, selected this invasive method in the asymptomatic patient vignette and 201 (62.4%), P < .05, in the symptomatic patient vignette.
Most (67.9%) clinicians stated there was no barrier to using the adolescent preferred method. The most commonly cited reason for not using the adolescent-preferred method was "the method is not recommended" (14.2%). Other less common barriers were "lack of trust in the patient to correctly collect specimen" (6.6%), "lack of equipment" (3.5%), and "do not know" (7.9%).
Discussion
Most clinicians think adolescents prefer urine samples for chlamydia/gonorrhea testing. This study demonstrates that clinicians have a good understanding of adolescents' preferred method for specimen collection since these results concur with previous studies illustrating adolescents prefer less invasive methods (urine samples, followed by vaginal swabs). 6, 7 Yet when the clinician's practice was tested using hypothetical patient vignettes, significantly fewer clinicians chose to use a less invasive specimen collection method for chlamydia/gonorrhea testing in symptomatic females. Most clinicians selected invasive cervical swabs in the symptomatic female vignette. Although most clinicians stated there was no barrier to using less invasive methods, less than half made clinical decisions in accordance with perceived patient preference despite being medically appropriate. In fact, the many providers thought that noninvasive collection method was not the appropriate test, which is not consistent with CDC recommendations. It may be that clinicians use commonsense to assume adolescents prefer less invasive methods, but are not actually familiar with supporting literature. This is likely the case as our results demonstrate that clinicians are not up to date with the most current CDC guidelines in regard to recommended specimen collection for chlamydia/gonorrhea.
Since we demonstrated that clinicians do have insight to adolescent preferences, it is now important to align practice with preferences and use less invasive methods regardless of patient symptomatology. Future research is needed to make clinician practice congruent with patient preferences when appropriate. Hopefully, aligning practice and preference will increase adolescent willingness to be tested, leading to increased testing in this at-risk population.
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